Anzeige
Mehr »
Samstag, 28.02.2026 - Börsentäglich über 12.000 News
Wegweisende News: NurExone - Pionier der regenerativen neuronalen Medizin!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Investing.com

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
FrCalumet Q4 2025 slides: debt cut $220M amid profitability challenges
FrNIQ Q4 2025 slides: AI powers revenue beat, 410 bps margin expansion
FrAtrium Mortgage Q4 2025 slides: steady returns amid revenue decline
FrBrightSpring Q4 2025 slides: revenue surges 29%, margins expand
FrCraig-Hallum raises Lindblad Expeditions stock price target on Disney partnership
FrCraig-Hallum cuts PureCycle Technologies stock price target on execution concerns
FrCraig-Hallum cuts Nuscale Power stock price target on commercialization focus
FrCraig-Hallum raises Park Dental stock price target on growth outlook
FrCraig-Hallum cuts Thryv stock price target on strategic pivot
FrBlackSky stock price target raised to $25 by Craig-Hallum on Gen-3 imagery
FrTD Cowen reiterates Intuit stock rating on solid quarter results
FrWarner Brothers Discovery stock holds at Hold rating by TD Cowen
FrCraig-Hallum raises Arhaus stock price target on delivery gains
FrCraig-Hallum cuts Delcath Systems stock price target on revenue guide
FrOxford Nanopore wins patent infringement concession from MGI
FrParatus Energy Q4 2025 slides: cash flow surges on Mexico collections
FrFulgent Q4 2025 slides: EPS beats, but customer loss drives stock plunge
FrCarter's Q4 2025 slides: tariff pressures squeeze margins despite sales beat
FrSiemens launches AI toolkit for chip verification workflows
FrBMO cuts Zscaler stock price target on growth durability concerns
FrBMO cuts Vital Farms stock price target on ERP impact concerns
FrStifel raises Aclaris Therapeutics stock price target to $3 on pipeline
FrRaymond James cuts GoodRx stock price target on pharma headwinds
FrAtkinsRéalis Q4 2025 slides: nuclear surges as backlog hits record
FrB3 Q4 2025 slides: revenue jumps 11%, EBITDA margin hits 69%